Declarite 500 mg I.V. Lyophilized Powder and Solvent for Preparing Solution for Infusion, 1 vial + 1 solvent ampoule
Turkey·Pharmaceutical Product·DEVA HOLDİNG A.Ş.·Licensed May 12, 2023- Product ID (UID)
- 64cf9bcffd9cc09db16382f1bf364928
- License Number
- 2023/172
- Barcode
- 8699525798565
- ATC Code
- J01FA09
- License Holder
- DEVA HOLDİNG A.Ş.
- Active Ingredient (EN)
- Klaritromisin
- License Date
- May 12, 2023
Access comprehensive regulatory information for Declarite 500 mg I.V. Lyophilized Powder and Solvent for Preparing Solution for Infusion, 1 vial + 1 solvent ampoule in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 64cf9bcffd9cc09db16382f1bf364928 with license number 2023/172and contains active ingredient Klaritromisin. The license is held by DEVA HOLDİNG A.Ş..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.